Jupiter Topco LLC Takes Position in ICU Medical, Inc. $ICUI

Jupiter Topco LLC acquired a new stake in ICU Medical, Inc. (NASDAQ:ICUI) in the second quarter, HoldingsChannel.com reports. The institutional investor acquired 2,781,620 shares of the medical instruments supplier’s stock, valued at approximately $407,786,000. Jupiter Topco LLC owned approximately 0.11% of ICU Medical at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the business. Legal & General Group Plc bought a new position in ICU Medical during the second quarter worth about $8,444,000. The Manufacturers Life Insurance Company acquired a new position in ICU Medical in the second quarter valued at about $28,652,000. Cetera Trust Company N.A bought a new stake in shares of ICU Medical in the second quarter worth about $328,000. Emerald Investment Advisers LLC bought a new stake in shares of ICU Medical in the second quarter worth about $3,711,000. Finally, William Blair Investment Management LLC bought a new stake in shares of ICU Medical in the second quarter worth about $25,242,000. Institutional investors and hedge funds own 96.10% of the company’s stock.

Analyst Upgrades and Downgrades

ICUI has been the topic of several recent analyst reports. Jefferies Financial Group upgraded ICU Medical to a “strong-buy” rating in a report on Thursday, May 7th. BTIG Research increased their target price on ICU Medical from $170.00 to $200.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. Wall Street Zen upgraded shares of ICU Medical from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 8th. Zacks Research lowered shares of ICU Medical from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 28th. Finally, Raymond James Financial reiterated a “strong-buy” rating and issued a $200.00 price target on shares of ICU Medical in a report on Friday, August 7th. Two research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $192.80.

ICU Medical Stock Performance

ICUI opened at $182.24 on Wednesday. The company has a market capitalization of $4.55 billion, a price-to-earnings ratio of 154.44, a P/E/G ratio of 2.31 and a beta of 0.74. The business’s 50-day moving average price is $162.42 and its two-hundred day moving average price is $143.53. ICU Medical, Inc. has a 1 year low of $112.50 and a 1 year high of $192.85. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.43 and a quick ratio of 1.21.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $2.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.91 by $0.46. ICU Medical had a return on equity of 7.91% and a net margin of 1.39%.The business had revenue of $547.88 million during the quarter, compared to the consensus estimate of $533.44 million. During the same period last year, the company earned $2.10 earnings per share. ICU Medical’s quarterly revenue was up .5% on a year-over-year basis. ICU Medical has set its FY 2026 guidance at 8.600-9.000 EPS. Equities analysts expect that ICU Medical, Inc. will post 7.19 EPS for the current fiscal year.

Insider Buying and Selling at ICU Medical

In other news, Director Elisha W. Finney sold 378 shares of the firm’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $182.48, for a total transaction of $68,977.44. Following the completion of the transaction, the director directly owned 4,871 shares of the company’s stock, valued at $888,860.08. This trade represents a 7.20% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Christian B. Voigtlander sold 8,929 shares of ICU Medical stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $182.93, for a total transaction of $1,633,381.97. Following the completion of the sale, the chief operating officer owned 37,377 shares in the company, valued at $6,837,374.61. This trade represents a 19.28% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 16,974 shares of company stock valued at $3,085,844 over the last quarter. Insiders own 2.10% of the company’s stock.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.